Trupanion, Inc. $TRUP Shares Sold by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund cut its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 21.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 97,457 shares of the financial services provider’s stock after selling 26,872 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Trupanion were worth $2,496,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in TRUP. Parallel Advisors LLC grew its stake in shares of Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new position in shares of Trupanion during the fourth quarter valued at about $64,000. Kelleher Financial Advisors purchased a new position in shares of Trupanion in the 3rd quarter valued at approximately $74,000. Advisory Services Network LLC purchased a new position in shares of Trupanion in the 3rd quarter valued at approximately $160,000. Finally, Fifth Third Bancorp raised its position in shares of Trupanion by 2,911.1% in the 1st quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after purchasing an additional 7,336 shares during the last quarter.

Trupanion Trading Up 0.0%

Shares of NASDAQ:TRUP opened at $24.49 on Friday. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25. Trupanion, Inc. has a 52-week low of $21.16 and a 52-week high of $57.00. The stock has a market cap of $1.07 billion, a price-to-earnings ratio of 41.51 and a beta of 1.39. The business has a 50-day moving average price of $24.33 and a 200-day moving average price of $26.48.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. The firm had revenue of $384.05 million for the quarter, compared to analyst estimates of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.Trupanion’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.03) earnings per share. Equities analysts predict that Trupanion, Inc. will post 0.55 EPS for the current year.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 6,177 shares of Trupanion stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total transaction of $137,005.86. Following the completion of the sale, the chief financial officer directly owned 2,081 shares in the company, valued at approximately $46,156.58. The trade was a 74.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Steve Weinrauch sold 6,674 shares of the company’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president directly owned 78,062 shares in the company, valued at $1,717,364. This trade represents a 7.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 17,807 shares of company stock valued at $394,452. 5.58% of the stock is owned by insiders.

Analysts Set New Price Targets

TRUP has been the topic of several research analyst reports. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Cantor Fitzgerald decreased their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Bank of America lowered their price objective on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a research note on Friday, June 26th. Finally, Atlantic Securities set a $42.00 price objective on shares of Trupanion in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.